ReleaseWire Connect

Recent advancement in pneumonia testing systems such as the development of enhanced nucleic acid detection tests and advancement in POC tests is the major factor that contributes toward the growth of the pneumonia testing market. Moreover, increase in awareness toward early diagnosis and rise in government expenditures on health care fuel the market growth. However, limited detection capability & accuracy of some of the pneumonia testing products and regulatory & economic hurdles hamper the market growth. Conversely, the surge in adoption of molecular diagnostic testing and high untapped market potential in the developing economies are anticipated to provide lucrative opportunities for the market.

Various types of ablation processes are used, namely, radiofrequency ablation, cryoablation, laser ablation, electrical ablation, hydrothermal ablation, microwave ablation, ultrasonic ablation, and others. Doctors most commonly use ultrasonic ablation, which is a noninvasive treatment for the removal of diseased tissue by the employment of sound waves to reduce chronic low-back and neck pain caused due to degeneration of joints.

External Storage devices are not restricted to a particular device and can be moved from one place to another without any data interruption. These devices are comprised of all the addressable data that do not belong to the main memory of the system. Moreover, external storage systems are also very convenient in transportation of data from one system to another.

The global clinical trials management market is driven by increase in adoption of clinical trial management system (CTMS) in clinical trials, growth in the number of clinical trials, surge in the number of product launches, favorable government initiatives supporting the use of CTMS, and rise in R&D activities expenditure of pharmaceutical and bio-pharmaceutical companies. However, dearth of skilled professionals to operate advanced CTMS solutions and high cost of CTMS solutions restrain the market growth. Conversely, development of advanced software with high accuracy and efficiency provides lucrative opportunities for the market growth.

Selected Reaction Monitoring uses mass spectroscopy, which specifically targets and detects the required proteins and specifically look for peptides and protein fragments of interest. Increase in R&D in the field of biology is expected to drive the market during the analysis period. However, selected reaction monitoring process is time consuming and hence anticipated to inhibit the growth of the market.

Pyrogen Testing also determines the presence of microbes and their metabolites in drugs during the manufacturing process. Pyrogen testing is carried out during drugs and vaccine manufacturing process to prevent contamination and to ensure the absence of toxic molecular products.

According to a new report published by Allied Market Research, titled, Copper & Copper Manufactured Products Market by Product Type and Geography, the copper & copper manufactured products market size was valued at $140,851 million in 2016, and is projected to reach $147,623 million by 2023, growing at a CAGR of 0.8% from 2017 to 2023. Copper is said to be one of the ideal choices for a plumbing system, as its joints can withstand rapid pressure and temperature changes. Moreover, more than 85% of the U.S. homeowners have installed copper plumbing systems because it can outlast the life of home. Copper piping requires very few or less support and yet can handle extreme weather conditions. Thus, U.S. was the highest revenue country in North America in 2016.

According to a new report published by Allied Market Research, titled, Stroke Management Market by Type and Application: Global Opportunity Analysis and Industry Forecast, 2017-2023, the global stroke management market was valued at $22,581 million in 2016, and is estimated to reach $36,756 million by 2023, growing at a CAGR of 7.1% from 2017 to 2023. The diagnostics segment held more than five-seventh share of the total market in 2016.

According to a new report published by Allied Market Research, titled, 3D Printed Drugs Market, Spritam is the only 3D printed drug available in the market since 2016 to treat epilepsy. The potential market for other 3D printed drugs (moderate growth scenario) is estimated to be $278 million in 2020, and would reach $522 million by 2030, growing at a CAGR of 6.5% from 2020 to 2030. U.S. market holds the highest market share in 2020.

The global vaccines market was valued at $31,216 million in 2016, and is expected to garner $65,148 million by 2023, growing at a CAGR of 10.9% from 2017 to 2023, according to a recent report published by Allied Market Research titled, "Vaccines Market by Technology, Indication, and End Use: Global Opportunity Analysis and Industry Forecast, 2017-2023." The conjugate vaccines sector occupied over one-third of the global market in 2016.